100 Participants Needed

Prosthetic Foot Testing for Amputation

Recruiting at 1 trial location
DC
EG
Overseen ByElizabeth G Halsne, PhD, CPO
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Seattle Institute for Biomedical and Clinical Research
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

Objective/Hypotheses and Specific Aims: The first aim of this proposal is to determine the effects of commercial prosthetic feet of varying stiffness on stability and falls-related outcomes in Veterans with TTA. The second aim is to determine whether a PFE can be used to predict stability and balance-confidence outcomes with corresponding commercial prosthetic feet. The third and final aim is to determine whether a brief trial of commercial prosthetic feet can predict longer-term stability and balance-confidence outcomes in Veterans with TTA. Study Design: The investigators will use a participant blinded cross-over study with repeated measurements in Veterans and Service members with TTA. Up to 50 participants will be enrolled at each of the two study sites VA Puget Sound and VA Minneapolis. Participants will complete up to 6 visits. After an initial assessment visit, participants will be assigned to the 'high' or 'low' mobility group, and then during visit 2 they will be randomized to use the PFE in three foot modes or the three corresponding actual (commercially available) feet during walking tests on difference surfaces in the laboratory (cross-slopes, inclines, even, and uneven ground). During visit 3 participants will repeat the procedures in the other condition (e.g., PFE if visit 2 included actual feet testing). At the end of visit 3 participants will be fit with one of the actual feet and wear it at home and in the community for approximately one week. At visit 4 participants will be fit with the next actual foot and repeat the 1 week use window. The same process will be followed for the final foot at visit 5, and the study foot will be returned at visit 6.

Do I need to stop taking my current medications for the trial?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment involving commercially available prosthetic feet and a multiaxial prosthetic foot emulator for amputation?

The research shows that different types of prosthetic feet can lead to functional improvements in people with transtibial amputations, as measured by tests like the Amputee Mobility Predictor. Additionally, the six-minute walk test is a reliable way to assess the functional abilities of prosthesis users, which can help in prescribing the right prosthetic foot.12345

Is the use of prosthetic feet generally safe for humans?

Research on prosthetic feet highlights the importance of safety during testing and training, with protocols in place to manage risks like loss of balance. Studies show that while there can be discomfort and pain, patient satisfaction is generally high, and safety measures like using a safety harness are recommended for additional protection.26789

How does the treatment of commercially available prosthetic feet differ from other treatments for amputation?

This treatment is unique because it involves using commercially available prosthetic feet, which are tested for their mechanical properties like stiffness and ankle torque-angle characteristics. Unlike other treatments, this approach allows for the customization of prosthetic feet to match individual needs, potentially improving comfort and gait for amputees.710111213

Research Team

DC

David C Morgenroth, MD

Principal Investigator

VA Puget Sound Health Care System

Eligibility Criteria

This trial is for Veterans with a below-knee amputation on one leg who've been walking with a prosthetic limb for at least six months. They must have a well-fitting prosthetic socket and be able to walk sufficiently for the trials. Those over 263lbs, with multiple amputations, or significant ambulation impairments are excluded.

Inclusion Criteria

I have one leg amputated below the knee.
My prosthetic socket fits comfortably.
I have been using a prosthetic limb for walking for over six months.
See 2 more

Exclusion Criteria

My weight is over 263lbs.
I am able to understand and communicate my consent to participate.
I am unable to make medical decisions for myself.
See 5 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Initial Assessment and Randomization

Participants undergo an initial assessment and are assigned to mobility groups, followed by randomization to use the PFE or commercial feet

1 week
1 visit (in-person)

Cross-over Testing

Participants test the PFE and commercial feet under different walking conditions in a cross-over design

3 weeks
3 visits (in-person)

Home and Community Use

Participants use each commercial foot at home and in the community for approximately one week per foot

3 weeks
3 visits (in-person)

Follow-up

Participants are monitored for stability and balance-confidence outcomes after using the commercial feet

4 weeks

Treatment Details

Interventions

  • Commercially available prosthetic feet
  • Multiaxial Prosthetic Foot Emulator
Trial Overview The study tests how different stiffness in commercial prosthetic feet affects stability and fall-related outcomes. It involves up to six visits where participants use both a Prosthetic Foot Emulator (PFE) and actual commercial feet across various surfaces, followed by home use of these feet.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Multiaxial Prosthetic Foot Emulator (PFE)Experimental Treatment1 Intervention
The multiaxial Prosthetic Foot Emulator (PFE) is a customizable robotic prosthetic foot that can mimic commercial feet to predict how prosthesis users will respond to candidate feet. Participants will walk with the PFE using three different modes (emulating three commercial feet) under different walking conditions.
Group II: Commercially available prosthetic feetActive Control1 Intervention
Participants will walk under different walking conditions using three different commercial prosthetic feet.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Seattle Institute for Biomedical and Clinical Research

Lead Sponsor

Trials
55
Recruited
13,700+

VA Puget Sound Health Care System

Collaborator

Trials
67
Recruited
225,000+

Minneapolis Veterans Affairs Medical Center

Collaborator

Trials
77
Recruited
355,000+

University of Chicago

Collaborator

Trials
1,086
Recruited
844,000+

Findings from Research

In a study involving 10 individuals with unilateral transtibial limb loss, standardized functional prosthetic gait training did not show significant improvements in self-report measures or performance-based tests, except for the Amputee Mobility Predictor (AMPPRO) in those with peripheral vascular disease (PVD).
The Proprio foot demonstrated significant differences in mobility outcomes compared to other prosthetic feet, particularly in the AMPPRO and 6-minute walk test (6MWT), highlighting its potential benefits for users with PVD.
Application of self-report and performance-based outcome measures to determine functional differences between four categories of prosthetic feet.Gailey, RS., Gaunaurd, I., Agrawal, V., et al.[2022]
In a study of 60 adults with transtibial amputations, mobility scores were the lowest, indicating challenges in ambulation and transfers, with average scores of 55.3 and 64.6 respectively, despite all participants using a prosthesis for at least 6 months.
Psychosocial responses were rated highest, with perceived responses scoring 86.6, suggesting that emotional and social aspects of living with a prosthesis may be more positively perceived than functional mobility, which contrasts with typical expectations in rehabilitation.
Health related quality of life in patients with dysvascular transtibial amputation.Harness, N., Pinzur, MS.[2022]
The instrumented version of the Four Square Step Test (FSST) demonstrated good to excellent test-retest reliability for measuring stepping patterns in 20 adults with unilateral transfemoral amputation, indicating it is a reliable tool for assessing functional performance.
Significant differences were found between two microprocessor knees, suggesting that one knee provided functional improvements over the other, which can help guide decisions in prosthetic selection for better mobility.
Instrumented Four Square Step Test in Adults with Transfemoral Amputation: Test-Retest Reliability and Discriminant Validity between Two Types of Microprocessor Knees.Gouelle, A., Highsmith, MJ.[2022]

References

Application of self-report and performance-based outcome measures to determine functional differences between four categories of prosthetic feet. [2022]
Health related quality of life in patients with dysvascular transtibial amputation. [2022]
Instrumented Four Square Step Test in Adults with Transfemoral Amputation: Test-Retest Reliability and Discriminant Validity between Two Types of Microprocessor Knees. [2022]
Establishing K-levels and prescribing transtibial prostheses using six-minute walk test and one-leg standing test on prosthesis: a retrospective audit. [2022]
Pressure casting technique for transtibial prosthetic socket fit in developing countries. [2022]
Design of a stepwise safety protocol for lower limb prosthetic risk management in a clinical investigation. [2022]
Quality benchmark for trans-tibial prostheses in low-income countries. [2022]
OASIS 2: Mobility differences with specific prosthetic feet across procedure codes. [2022]
Design of an open-source transfemoral, bypass socket. [2021]
Effects of shear force reduction during mechanical testing and day-to-day variation on stiffness of commercial prosthetic feet: a technical note. [2022]
11.United Statespubmed.ncbi.nlm.nih.gov
Emulating the Effective Ankle Stiffness of Commercial Prosthetic Feet Using a Robotic Prosthetic Foot Emulator. [2022]
12.United Statespubmed.ncbi.nlm.nih.gov
Physical response of SACH feet under laboratory testing. [2004]
13.United Statespubmed.ncbi.nlm.nih.gov
Normal and pathological human gait analysis using miniature triaxial shoe-borne load cells. [2013]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of ServiceยทPrivacy PolicyยทCookiesยทSecurity